Infectious Diseases in Critical Care Medicine

(ff) #1

  1. Slaughter S, Hayden MK, Nathan C, et al. A comparison of the effect of universal use of gloves and
    gowns with that of glove use alone on acquisition of vancomycin-resistant enterococci in a medical
    intensive care unit. Ann Intern Med 1996;125(6):448–456.

  2. Gardiner D, Murphey S, Ossman E, et al. Prevalence and acquisition of vancomycin-resistant
    enterococci in a medical intensive care unit. Infect Control Hosp Epidemiol 2002;23(8):466–468.

  3. Padiglione AA, Wolfe R, Grabsch EA, et al. Risk factors for new detection of vancomycin-resistant
    enterococci in acute-care hospitals that employ strict infection control procedures. Antimicrob
    Agents Chemother 2003;47(8):2492–2498.

  4. Martinez JA, Ruthazer R, Hansjosten K, et al. Role of environmental contamination as a risk factor
    for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care
    unit. Arch Intern Med 2003;163(16):1905–1912.

  5. Warren DK, Nitin A, Hill C, et al. Occurrence of co-colonization or co-infection with vancomycin-
    resistant enterococci and methicillin-resistantStaphylococcus aureusin a medical intensive care unit.
    Infect Control Hosp Epidemiol 2004;25(2):99–104.

  6. Donskey CJ, Chowdhry TK, Hecker MT, et al. Effect of antibiotic therapy on the density of
    vancomycin-resistant enterococci in the stool of colonized patients. N Engl J Med 2000;343(26):
    1925–1932.

  7. Carmelli Y, Samore MH, Huskins WC. The association between antecedent vancomycin treatment
    and hospital-acquired vancomycin-resistant enterococci. A meta-analysis. Arch Intern Med 1999;
    159(20):2461–2468.

  8. D’Agata EMC, Green WK, Schulman G, et al. Vancomycin-resistant enterococci among chronic
    hemodialysis patients: a prospective study of acquisition. Clin Infect Dis 2001;32(1):23–29.

  9. Lee HK, Lee WG, Cho SR. Clinical and molecular biological analysis of a nosocomial outbreak of
    vancomycin-resistant enterococci in a neonatal intensive care unit. Acta Pediatr 1999;88(6):651–654.

  10. Yu ̈ce A, Karaman M, Gu ̈lay Z, et al. Vancomycin-resistant enterococci in neonates. Scand J Infect Dis
    2001;33(11):803–805.

  11. Rupp ME, Marion N, Fey PD, et al. Outbreak of vancomycin-resistantEnterococcus faeciumin a
    neonatal intensive care unit. Infect Control Hosp Epidemiol 2001;22(5):301–303.

  12. Duchon J, Graham P III, Della-Latta P, et al. Epidemiology of enterococci in a neonatal intensive care
    unit. Infect Control Hosp Epidemiol 2008;29(4):374–376.

  13. Hospital Infection Control Practices Advisory Committee (HICPAC). Recommendations for
    preventing the spread of vancomycin resistance. Infect Control Hosp Epidemiol 1995;16(2):105–113.

  14. Leber AL, Hindler JF, Kato EO, et al. Laboratory-based surveillance for vancomycin-resistant
    enterococci: utility of screening stool specimens submitted forClostridium difficiletoxin assay. Infect
    Control Hosp Epidemiol 2001;22(3):160–164.

  15. D’Agata EMC, Gautam S, Green WK, et al. High rate of false-negative results of the rectal swab
    culture method in detection of gastrointestinal colonization with vancomycin-resistant enterococci.
    Clin Infect Dis 2002;34(2):167–172.

  16. Weinstein JW, Tallapragada S, Farrel P, et al. Comparison of rectal and perirectal swabs for detection
    of colonization with vancomycin-resistant enterococci. J Clin Microbiol 1996;34(1):210–212.

  17. Ostrowsky BE, Trick WE, Sohn AH, et al. Control of vancomycin-resistant Enterococcus in health
    care facilities in a region. N Engl J Med 2001;344(19):1427–1433.

  18. Siddiqui AH, Harris AD, Hebden J, et al. The effect of active surveillance for vancomycin-resistant
    enterococci in high-risk units on vancomycin-resistant enterococci incidence hospital-wide. Am J
    Infect Control 2002;30(1):40–43.

  19. Calfee DP, Giannetta ET, Durbin LJ, et al. Control of endemic vancomycin-resistant Enterococcus
    among inpatients at a university hospital. Clin Infect Dis 2003;37(3):326–332.

  20. Price CS, Paule S, Noskin GA, et al. Active surveillance reduces the incidence of vancomycin-
    resistant enterococcal bacteremia. Clin Infect Dis 2003;37(7):921–928.

  21. Shadel BN, Puzniak LA, Gillespie KN, et al. Surveillance for vancomycin-resistant enterococci: type,
    rates, costs, and implications. Infect Control Hosp Epidemiol 2006;27(10):1068–1075.

  22. Byers KE, Anglimn AM, Anneski CJ, et al. Duration of colonization with vancomycin-resistant
    Enterococcus. Infect Control Hosp Epidemiol 2002;23(4):207–211.

  23. Noskin GA, Bednarz P, Suriano T, et al. Persistent contamination of fabric covered furniture by
    vancomycin-resistant enterococci: implications for upholstery selection in hospitals. Am J Infect
    Control 2000;28(4):311–313.

  24. Hayden MK, Bonten MJM, Blom DW, et al. Reduction in acquisition of vancomycin-resistant
    Enterococcus after enforcement of routine environmental cleaning measures. Clin Infect Dis 2006;42
    (11):1552–1560.

  25. Drees M, Snydman DR, Schmid CH, et al. Prior environmental contamination increases the risk of
    acquisition of vancomycin-resistant enterococci. Clin Infect Dis 2008;46(5):678–685.


126 Mayhall

Free download pdf